Your browser doesn't support javascript.
loading
The Occurrence of Primary Hepatic Adenoma in Deceased Donor Renal Transplant Recipient
Liao, Yu-Tso; Jeng, Yung-Ming; Lee, Yu-Hsin; Tsai, Meng-Kun; Hu, Ruy-Heng; Ho, Ming-Chih.
  • Liao, Yu-Tso; National Taiwan University Hospital. Department of Surgery. Division of General Surgery. Yuan-Lin. CN
  • Jeng, Yung-Ming; National Taiwan University Hospital. Department of Surgery. Division of General Surgery. Yuan-Lin. CN
  • Lee, Yu-Hsin; National Taiwan University Hospital. Department of Surgery. Division of General Surgery. Yuan-Lin. CN
  • Tsai, Meng-Kun; National Taiwan University Hospital. Department of Surgery. Division of General Surgery. Yuan-Lin. CN
  • Hu, Ruy-Heng; National Taiwan University Hospital. Department of Surgery. Division of General Surgery. Yuan-Lin. CN
  • Ho, Ming-Chih; National Taiwan University Hospital. Department of Surgery. Division of General Surgery. Yuan-Lin. CN
Int. braz. j. urol ; 40(1): 118-122, Jan-Feb/2014. tab, graf
Artigo em Inglês | LILACS | ID: lil-704172
ABSTRACT
Main findings: We reported a case of new-onset, multi-focal hepatic adenoma in an 18 year-old man with no classic risk factors occurring forty months after a renal transplant from a cadaver donor. Histopathology of the adenoma was examined and genotype and phenotype were also analyzed. Histopathologic examination of the adenoma showed no malignancy. Genotype and phenotype analysis revealed no HNF1α or β-catenin gene mutations and no inflammatory infiltration. The patient was well and disease-free postoperatively. Case hypothesis: Hepatic adenoma occurs mostly in those taking oral contraceptives or androgenic-anabolic steroids or in those with hereditary diseases. Hepatic adenoma in a renal transplant recipient is rare and has only been reported in one case with glycogen storage disease type Ia. Immunosuppressive treatment might have contributed to the development of the neoplasm. Promising future implications: Although malignant change occurs most often in β-catenin gene mutation hepatic adenoma, surgical resection of the adenoma in a patient under immunosuppressive therapy should be considered in order to avoid the possibility of malignant transformation or hemorrhagic rupture. .
Assuntos


Texto completo: DisponíveL Índice: LILACS (Américas) Assunto principal: Doadores de Tecidos / Adenoma / Transplante de Rim / Neoplasias Hepáticas Tipo de estudo: Fatores de risco Limite: Adolescente / Humanos / Masculino Idioma: Inglês Revista: Int. braz. j. urol Assunto da revista: Urologia Ano de publicação: 2014 Tipo de documento: Artigo País de afiliação: China Instituição/País de afiliação: National Taiwan University Hospital/CN

Similares

MEDLINE

...
LILACS

LIS


Texto completo: DisponíveL Índice: LILACS (Américas) Assunto principal: Doadores de Tecidos / Adenoma / Transplante de Rim / Neoplasias Hepáticas Tipo de estudo: Fatores de risco Limite: Adolescente / Humanos / Masculino Idioma: Inglês Revista: Int. braz. j. urol Assunto da revista: Urologia Ano de publicação: 2014 Tipo de documento: Artigo País de afiliação: China Instituição/País de afiliação: National Taiwan University Hospital/CN